US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.980
- -0.020-0.22%
Close Nov 22 16:00 ET
- 8.980
- 0.0000.00%
Post 20:01 ET
175.39MMarket Cap-6163P/E (TTM)
9.000High8.750Low31.54KVolume8.922Open9.000Pre Close281.28KTurnover1.13%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High32.77P/B25.14MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM2.78%Amplitude5.510Historical Low8.919Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Actuate Therapeutics Stock Forum
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...
No comment yet